Document is current
Any future updates will be listed below
-
Authors
Nishiura, Hironobu
Takahashi, Masaya https://orcid.org/0000-0003-2649-4638
Mori, Katsuhito
Sugimoto, Takashi
Emoto, Masanori
Nakamura, Yasutaka
- License Information
-
More Information
Article History
Received: 15 November 2023
Accepted: 6 February 2024
First Online: 22 February 2024
Declarations
:
: This study adhered to the guidelines of the 1964 Declaration of Helsinki and its later amendments and was approved by the institutional review board of the Osaka Metropolitan University Hospital, which waived the requirement for informed consent owing to the retrospective nature of the study.
: Not applicable.
: KM received research funding from Mitsubishi Tanabe Pharma Corporation, Sanofi K.K., Kyowa Kirin, and Sumitomo Pharma and received a Speaker’s Bureau from Mitsubishi Tanabe Pharma Corporation, AstraZeneca K.K., Nippon Boehringer Ingelheim, Mochida Pharmaceutical, and Kyowa Kirin. ME received research funding from Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin, Sumitomo Pharma, Eisai, Chugai Pharmaceutical, Bayer Yakuhin, and Nippon Boehringer Ingelheim, and received a Speaker’s Bureau from AstraZeneca K.K., Nippon Boehringer Ingelheim, Sumitomo Pharma, Sanofi, Ono Pharmaceutical and Kyowa Kirin.
